Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Shares Outstanding (2019 - 2022)

Historic Shares Outstanding for Avidity Biosciences (RNA) over the last 4 years, with Q3 2022 value amounting to $54.4 million.

  • Avidity Biosciences' Shares Outstanding rose 1609.7% to $54.4 million in Q3 2022 from the same period last year, while for Sep 2022 it was $54.4 million, marking a year-over-year increase of 1609.7%. This contributed to the annual value of $47.8 million for FY2021, which is 2711.01% up from last year.
  • Latest data reveals that Avidity Biosciences reported Shares Outstanding of $54.4 million as of Q3 2022, which was up 1609.7% from $52.1 million recorded in Q2 2022.
  • In the past 5 years, Avidity Biosciences' Shares Outstanding ranged from a high of $54.4 million in Q3 2022 and a low of $2.9 million during Q2 2019
  • Moreover, its 4-year median value for Shares Outstanding was $37.6 million (2020), whereas its average is $32.2 million.
  • As far as peak fluctuations go, Avidity Biosciences' Shares Outstanding surged by 118209.77% in 2020, and later skyrocketed by 36.77% in 2021.
  • Over the past 4 years, Avidity Biosciences' Shares Outstanding (Quarter) stood at $3.0 million in 2019, then skyrocketed by 1156.91% to $37.6 million in 2020, then grew by 27.11% to $47.8 million in 2021, then increased by 14.01% to $54.4 million in 2022.
  • Its Shares Outstanding was $54.4 million in Q3 2022, compared to $52.1 million in Q2 2022 and $49.3 million in Q1 2022.